OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
+1.85%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$123M
AUM Growth
+$123M
Cap. Flow
+$38M
Cap. Flow %
30.82%
Top 10 Hldgs %
95.81%
Holding
15
New
3
Increased
–
Reduced
–
Closed
1

Top Buys

1
LXEO icon
Lexeo Therapeutics
LXEO
$29M
2
ENGN icon
enGene Holdings
ENGN
$10.4M
3
ENGNW icon
enGene Holdings Inc. Warrants
ENGNW
$404K

Top Sells

1
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
$1.76M

Sector Composition

1 Healthcare 99.67%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LXEO icon
1
Lexeo Therapeutics
LXEO
$259M
$29M 23.46% +2,157,623 New +$29M
REPL icon
2
Replimune Group
REPL
$422M
$25.3M 20.5% 3,001,319 – –
NUVB icon
3
Nuvation Bio
NUVB
$1.02B
$22.8M 18.44% 15,072,340 – –
ENGN icon
4
enGene Holdings
ENGN
$236M
$10.4M 8.46% +1,131,175 New +$10.4M
MORF
5
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$8.95M 7.25% 309,846 – –
SPRB
6
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$6.33M 5.13% 2,161,022 – –
KRON
7
DELISTED
Kronos Bio
KRON
$4.77M 3.87% 3,818,283 – –
IMA
8
ImageneBio, Inc. Common Stock
IMA
$150M
$4.43M 3.59% 2,249,123 – –
SANA icon
9
Sana Biotechnology
SANA
$777M
$3.44M 2.79% 843,750 – –
THRX
10
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$2.88M 2.33% 711,479 – –
IMUX icon
11
Immunic
IMUX
$80.9M
$2.68M 2.17% 1,788,160 – –
SYRS
12
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.96M 1.59% 251,270 – –
ENGNW icon
13
enGene Holdings Inc. Warrants
ENGNW
$7.08M
$404K 0.33% +475,077 New +$404K
SNTI icon
14
Senti Biosciences
SNTI
$38.5M
$129K 0.1% 195,792 – –
ALPN
15
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
– – -153,700 Closed -$1.76M